Mylan (MYL) acquires Agila Specialties, a developer, manufacturer and marketer of high-quality...

|About: Mylan Inc (MYL)|By:, SA News Editor

Mylan (MYL) acquires Agila Specialties, a developer, manufacturer and marketer of high-quality generic injectable products, from Strides Arcolab for $1.6B in cash. The acquisition significantly expands MYL's global injectables platform and will provide entry into new high-growth geographic markets. The acquisition is expected to close in Q4 of 2013 should be immediately accretive to earnings. Shares +1.8% AH.